Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis
@article{PCM7703,
author = {Edyta Maria Urbanska},
title = {Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis},
journal = {Precision Cancer Medicine},
volume = {6},
number = {0},
year = {2023},
keywords = {},
abstract = {},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/7703}
}